Entry |
|
Name |
Deligoparin sodium (USAN/INN) |
Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
|
Remark |
Product (DG00150): | D02112<JP/US> D04427<JP> D03674<JP/US> D04977<JP> D03353<JP/US> |
|
Efficacy |
Anticoagulant, Anti-inflammatory, Antithrombin III activator |
Comment |
Heparin sodium [DR: D02112] salt. Molecular weight is approximately 3,200 daltons +- 650 daltons.
Low molecular weight heparin (LMWH)
Treatment of inflammatory bowel disease
|
Target |
|
Pathway |
hsa04610 | Complement and coagulation cascades |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
DG00150 Heparin
D03673 Deligoparin sodium
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Organismal systems
Complement and coagulation
SERPINC1 (AT3)
D03673 Deligoparin sodium (USAN/INN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
DG00150 Heparin
|
Other DBs |
|
LinkDB |
|